Exosomal-mediated transfer of APCDD1L-AS1 induces 5-fluorouracil resistance in oral squamous cell carcinoma via miR-1224-5p/nuclear receptor binding SET domain protein 2 (NSD2) axis

References

• Chi AC, Day TA, Neville BW. Oral cavity and oropharyngeal squamous cell carcinoma–an update. CA Cancer J Clin. 2015;65:401–421.
   PubMed Web of Science ®Google Scholar
• Zhang X, Guo B, Zhu Y, et al. Up-regulation of plasma lncRNA CACS15 distinguished early-stage oral squamous cell carcinoma patient. Oral Dis. 2020;26:1619–1624.
   PubMed Web of Science ®Google Scholar
• Ren S, Cheng X, Chen M, et al. Hypotoxic and rapidly metabolic PEG-PCL-C3-ICG Nanoparticles for fluorescence-guided photothermal/photodynamic therapy against OSCC. ACS Appl Mater Interfaces. 2017;9:31509–31518.
   PubMed Web of Science ®Google Scholar
• Rapidis AD, Gullane P, Langdon JD, et al. Major advances in the knowledge and understanding of the epidemiology, aetiopathogenesis, diagnosis, management and prognosis of oral cancer. Oral Oncol. 2009;45:299–300.
   PubMed Web of Science ®Google Scholar
• Perez-Sayans M, Somoza-Martin JM, Barros-Angueira F, et al. Multidrug resistance in oral squamous cell carcinoma: the role of vacuolar ATPases. Cancer Lett. 2010;295:135–143.
   PubMed Web of Science ®Google Scholar
• Yoshitomi I, Kawasaki G, Yanamoto S, et al. Orotate phosphoribosyl transferase mRNA expression in oral squamous cell carcinoma and its relationship with the dihydropyrimidine dehydrogenase expression and the clinical effect of 5-fluorouracil. Oral Oncol. 2006;42:880–887.
   PubMed Web of Science ®Google Scholar
• Feng X, Luo Q, Zhang H, et al. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma. J Exp Clin Cancer Res. 2017;36:81.
   PubMed Web of Science ®Google Scholar
• Iyer MK, Niknafs YS, Malik R, et al. The landscape of long noncoding RNAs in the human transcriptome. Nat Genet. 2015;47:199–208.
   PubMed Web of Science ®Google Scholar
• Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov. 2011;1:391–407.
   PubMed Web of Science ®Google Scholar
• Wang J, Yu Z, Wang J, et al. LncRNA NUTM2A-AS1 positively modulates TET1 and HIF-1A to enhance gastric cancer tumorigenesis and drug resistance by sponging miR-376a. Cancer Med. 2020;9:9499–9510.
   PubMed Web of Science ®Google Scholar
• Zhou C, Yi C, Yi Y, et al. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/beta-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes. Mol Cancer. 2020;19:118.
   PubMed Web of Science ®Google Scholar
• Lei Y, Guo W, Chen B, et al. Tumorreleased lncRNA H19 promotes gefitinib resistance via packaging into exosomes in nonsmall cell lung cancer. Oncol Rep. 2018;40:3438–3446.
   PubMed Web of Science ®Google Scholar
• Ghafouri-Fard S, Abak A, Tondro Anamag F, et al. 5-Fluorouracil: a narrative review on the role of regulatory mechanisms in driving resistance to this chemotherapeutic agent. Front Oncol. 2021;11:658636.
   PubMed Web of Science ®Google Scholar
• Chaudhary R, Wang X, Cao B, et al. Long noncoding RNA, LINC00460, as a prognostic biomarker in head and neck squamous cell carcinoma (HNSCC). Am J Transl Res. 2020;12:684–696.
   PubMed Web of Science ®Google Scholar
• Wu J, Zheng C, Wang Y, et al. LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/miR-324-3p-SIRT5 axis in lung adenocarcinoma. Biomark Res. 2021;9:9.
   PubMed Web of Science ®Google Scholar
• Wang X, Lan Z, He J, et al. LncRNA SNHG6 promotes chemoresistance through ULK1-induced autophagy by sponging miR-26a-5p in colorectal cancer cells. Cancer Cell Int. 2019;19:234.
   PubMed Web of Science ®Google Scholar
• Han P, Li JW, Zhang BM, et al. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Mol Cancer. 2017;16:9.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Koike T, Nakatsuka A, et al. Dihydropyrimidine dehydrogenase expression predicts survival outcome and chemosensitivity to 5-fluorouracil in patients with oral squamous cell carcinoma. Oral Oncol. 2005;41:38–47.
   PubMed Web of Science ®Google Scholar
• Feng J, Li J, Qie P, et al. Long non-coding RNA (lncRNA) PGM5P4-AS1 inhibits lung cancer progression by up-regulating leucine zipper tumor suppressor (LZTS3) through sponging microRNA miR-1275. Bioengineered. 2021;12:196–207.
   Google Scholar
• Zhang L, Kang W, Lu X, et al. LncRNA CASC11 promoted gastric cancer cell proliferation, migration and invasion in vitro by regulating cell cycle pathway. Cell Cycle. 2018;17:1886–1900.
   PubMed Web of Science ®Google Scholar
• Zhang CC, Li Y, Feng XZ, et al. Circular RNA circ_0001287 inhibits the proliferation, metastasis, and radiosensitivity of non-small cell lung cancer cells by sponging microRNA miR-21 and up-regulating phosphatase and tensin homolog expression. Bioengineered. 2021;12:414–425.
   Google Scholar
• Cai L, Ye L, Hu X, et al. MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4. Bioengineered. 2021;12:440–449.
   PubMed Web of Science ®Google Scholar
• Li Z, Yu Z, Meng X, et al. LncRNA LINC00968 accelerates the proliferation and fibrosis of diabetic nephropathy by epigenetically repressing p21 via recruiting EZH2. Biochem Biophys Res Commun. 2018;504:499–504.
   PubMed Web of Science ®Google Scholar
• Aytes A, Giacobbe A, Mitrofanova A, et al. NSD2 is a conserved driver of metastatic prostate cancer progression. Nat Commun. 2018;9:5201.
   PubMed Web of Science ®Google Scholar
• Zhu L, Yu CL, Zheng Y. NSD2 inhibition suppresses metastasis in cervical cancer by promoting TGF-beta/TGF-betaRI/SMADs signaling. Biochem Biophys Res Commun. 2019;519:489–496.
   PubMed Web of Science ®Google Scholar
• He C, Liu C, Wang L, et al. Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma. Cell Death Dis. 2019;10:65.
   PubMed Web of Science ®Google Scholar
• Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3:330–338.
   PubMed Web of Science ®Google Scholar
• Nagata M, Nakayama H, Tanaka T, et al. Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma. Br J Cancer. 2011;105:1322–1330.
   PubMed Web of Science ®Google Scholar
• Zhang L, Meng X, Zhu XW, et al. Long non-coding RNAs in oral squamous cell carcinoma: biologic function, mechanisms and clinical implications. Mol Cancer. 2019;18:102.
   PubMed Web of Science ®Google Scholar
• Fang Z, Zhao J, Xie W, et al. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression. Cancer Med. 2017;6:2897–2908.
   PubMed Web of Science ®Google Scholar
• Wang R, Lu X, Yu R. lncRNA MALAT1 Promotes EMT process and cisplatin resistance of oral squamous cell carcinoma via PI3K/AKT/m-TOR signal pathway. Onco Targets Ther. 2020;13:4049–4061.
   PubMedGoogle Scholar
• Lian P, Wang Q, Zhao Y, et al. An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancer. Aging (Albany NY). 2019;11:6930–6940.
   PubMedGoogle Scholar
• Luo Y, Xuan Z, Zhu X, et al. Long non-coding RNAs RP5-821D11.7, APCDD1L-AS1 and RP11-277P12.9 were associated with the prognosis of lung squamous cell carcinoma. Mol Med Rep. 2018;17:7238–7248.
   PubMed Web of Science ®Google Scholar
• Qin X, Guo H, Wang X, et al. Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5. Genome Biol. 2019;20:12.
   PubMed Web of Science ®Google Scholar
• Qu L, Ding J, Chen C, et al. Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer Cell. 2016;29:653–668.
   PubMed Web of Science ®Google Scholar
• Dong H, Wang W, Chen R, et al. Exosome-mediated transfer of lncRNASNHG14 promotes trastuzumab chemoresistance in breast cancer. Int J Oncol. 2018;53:1013–1026.
   PubMed Web of Science ®Google Scholar
• Wang X, Yu H, Yu Z, et al. Exosomal lncRNA HEIH promotes cisplatin resistance in tongue squamous cell carcinoma via targeting miR-3619-5p/HDGF axis. Acta Histochem. 2020;122:151647.
   PubMed Web of Science ®Google Scholar
• Kang M, Ren M, Li Y, et al. Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA. J Exp Clin Cancer Res. 2018;37:171.
   PubMed Web of Science ®Google Scholar
• Tong Y, Yang L, Yu C, et al. Tumor-secreted exosomal lncRNA POU3F3 promotes cisplatin resistance in ESCC by inducing fibroblast differentiation into CAFs. Mol Ther Oncolytics. 2020;18:1–13.
   PubMed Web of Science ®Google Scholar
• Shin Low S, Pan Y, Ji D, et al. Smartphone-based portable electrochemical biosensing system for detection of circulating microRNA-21 in saliva as a proof-of-concept. Sens Actuators B Chem. 2020;308:127718.
   Web of Science ®Google Scholar
• Song NS, Pei ZD, Fu G. MiR-1224-5p acts as a tumor suppressor via inhibiting the malignancy of rectal cancer through targeting SLC29A3. IUBMB Life. 2020;72:2204–2213.
   PubMed Web of Science ®Google Scholar
• Kong L, Liu P, Zheng M, et al. The miR-1224-5p/ELF3 axis regulates malignant behaviors of pancreatic cancer via PI3K/AKT/Notch signaling pathways. Onco Targets Ther. 2020;13:3449–3466.
   PubMed Web of Science ®Google Scholar
• Wang J, Hu Y, Ye C, et al. miR-1224-5p inhibits the proliferation and invasion of ovarian cancer via targeting SND1. Hum Cell. 2020;33:780–789.
   PubMed Web of Science ®Google Scholar
• Qian J, Li R, Wang YY, et al. MiR-1224-5p acts as a tumor suppressor by targeting CREB1 in malignant gliomas. Mol Cell Biochem. 2015;403:33–41.
   PubMed Web of Science ®Google Scholar
• Shi ZZ, Wang WJ, Chen YX, et al. The miR-1224-5p/TNS4/EGFR axis inhibits tumour progression in oesophageal squamous cell carcinoma. Cell Death Dis. 2020;11:597.
   PubMed Web of Science ®Google Scholar
• Sudhakara Prasad K, Cao X, Gao N, et al. A low-cost nanomaterial-based electrochemical immunosensor on paper for high-sensitivity early detection of pancreatic cancer. Sens Actuators B Chem. 2020;305:127516.
   Web of Science ®Google Scholar
• Han X, Piao L, Xu X, et al. NSD2 promotes renal cancer progression through stimulating Akt/Erk signaling. Cancer Manag Res. 2020;12:375–383.
   PubMed Web of Science ®Google Scholar
• Chen LY, Zhi Z, Wang L, et al. NSD2 circular RNA promotes metastasis of colorectal cancer by targeting miR-199b-5p-mediated DDR1 and JAG1 signalling. J Pathol. 2019;248:103–115.
   PubMed Web of Science ®Google Scholar
• Stangl-Kremser J, Lemberger U, Hassler MR, et al. The prognostic impact of tumour NSD2 expression in advanced prostate cancer. Biomarkers. 2020;25:268–273.
   PubMed Web of Science ®Google Scholar